Showing results (91-100 of 490) with videos related to
Sort By:
Pageof 49
Infection and Immunity|April 18, 2000
Effects of Enterococcus faecalis fsr genes on production of gelatinase and a serine protease and virulenceX Qin, K V Singh, G M Weinstock, et al.Methods in Molecular Medicine|March 11, 2011
Application of molecular techniques to the study of nosocomial infections caused by enterococciT M Coque, P Seetulsingh, K V Singh, et al.Journal of Clinical Microbiology|February 12, 1998
Repetitive sequence-based PCR versus pulsed-field gel electrophoresis for typing of Enterococcus faecalis at the subspecies levelK Malathum, K V Singh, G M Weinstock, et al.International Journal of Molecular Medicine|December 16, 1998
Excitation-contraction-relaxation cycle: role of Ca2+-regulatory membrane proteins in normal, stimulated and pathological skeletal muscle (review)B E Murray, G R Froemming, P B Maguire, et al.The Journal of Infectious Diseases|October 21, 1998
Generation and testing of mutants of Enterococcus faecalis in a mouse peritonitis modelK V Singh, X Qin, G M Weinstock, et al.Meat Science|November 9, 2011
Intramuscular and subcutaneous lipid fatty acid profile composition in male and female foalsM V Sarriés, B E Murray, D Troy, et al.Microbial Drug Resistance (Larchmont, N.Y.)|April 20, 2001
In vitro activity of 19 antimicrobial agents against enterococci from healthy subjects and hospitalized patients and use of an ace gene probe from Enterococcus faecalis for species identificationR W Duh, K V Singh, K Malathum, et al.Antimicrobial Agents and Chemotherapy|April 2, 1999
In vitro activities of two ketolides, HMR 3647 and HMR 3004, against gram-positive bacteriaK Malathum, T M Coque, K V Singh, et al.Antimicrobial Agents and Chemotherapy|June 1, 1992
Comparative in vitro activity of PD 127391, a new fluoroquinolone agent, against susceptible and resistant clinical isolates of gram-positive cocciA G Miranda, A R Wanger, K V Singh, et al.Antimicrobial Agents and Chemotherapy|April 1, 1983
Bacteriological studies of the enteric flora of patients treated with bicozamycin (CGP 3543/E) for acute nonparasitic diarrheaP S Harford, B E Murray, H L DuPont, et al.Pageof 49